Search for: "BRISTOL-MYERS SQUIBB"
Results 721 - 740
of 866
Sorted by Relevance
|
Sort by Date
15 Jul 2019, 12:55 pm
There may have been a link between silicone implants (particularly ruptured ones) and auto-immune problems, and by the early 1990s, lawsuits were piling up against manufacturers of silicone implants, including Dow Corning, Baxter, and Bristol-Myers Squibb. [read post]
18 Jun 2012, 1:38 pm
., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]
28 Nov 2006, 4:11 pm
Anticipation does not require proof of "utility," or (in other words) "actual performance of suggestions in a disclosure," Bristol-Myers Squibb Co. v. [read post]
23 Jun 2011, 6:33 pm
AstraZeneca marketed Seroquel off-label for children and the elderly (another vulnerable population, often administered antipsychotics in nursing homes); Pfizer faced similar charges for Geodon (an antipsychotic); Eli Lilly for Zyprexa (an antipsychotic); Bristol-Myers Squibb for Abilify (another antipsychotic); and Forest Labs for Celexa (an antidepressant). [read post]
11 Jun 2018, 8:00 am
Supreme Court in Bristol-Myers Squibb rejected such an argument. [read post]
19 Oct 2020, 3:00 am
Doug will also be participating in our webcast next Thursday, October 29th – “Virtual Annual Meetings: What To Do Now” – along with CII’s Amy Borrus, Dorothy Flynn of Broadridge, Independent Inspector of Election Carl Hagberg and Bristol-Myers Squibb’s Kate Kelly. [read post]
29 Jul 2009, 6:45 am
Tafas v Doll (Patent Docs) US: For stem cells, it seems that conception is enough: University of Pittsburgh v Hedrick (Patent Docs) (Patents4Life) US: General Accountability Office report on Bayh-Dole: Leverage to promote commercialisation of federally-funded inventions (PatentBIOtech) US: AlphaVax seeks review of BPAI decision awarding priority of invention to Novartis in interference between patents related to Alphavirus (Patent Docs) US: Teva, Taro lobby US legislators on biogenerics… [read post]
11 Jan 2006, 8:21 am
The U.S. biotech firms have been brought together under the recently formed American BioIndustry Alliance, which includes pharmaceutical companies Merck, Pfizer, Bristol Myers-Squibb and Eli Lilly, as well as General Electric and Procter & Gamble. [read post]
20 Nov 2011, 10:31 pm
The court’s distinction is not a commercial one—and I would have thought that it would by now have been safely relegated to the dustbin of obsolete and antiquated notions; see Bristol-Myers Squibb Co. v. [read post]
19 Feb 2021, 2:28 am
This second appeal followed with Bristol Myers Squibb Co., Pfizer Inc., and Eli Lilly and Company, among others, filing dueling amicus briefs. [read post]
16 Jun 2011, 10:59 am
Yet, Edward Osei, an assistant professor of law at Widener University, who also formerly worked at AstraZeneca and Bristol Myers Squibb, said that although one product is injectable and the other is oral, this still may pose a concern under the agreement because both products serve the same patient population with the same prescribing physicians. [read post]
20 Jan 2010, 10:36 am
In addition, Time Warner, Genzyme, Bristol-Myers Squibb, International Paper, Pinnacle West Capital, and Liz Claiborne Inc. have filed similar no-action requests to exclude proposals with a 10 percent threshold, according to investors. [read post]
23 Feb 2007, 8:46 am
In early 2005, the United Brotherhood of Carpenters and Joiners of America, the Sheet Metal Workers International Association, and other labor pension funds founded a work group with companies like Bristol-Myers Squibb, Cinergy, Time Warner, and Chevron to address majority voting in director elections. [read post]
17 Jan 2018, 9:04 am
Bristol-Myers Squibb Canada Co. c. [read post]
9 Dec 2009, 3:59 pm
(Patent Docs) (SmartBrief) (GenericsWeb) OxyContin (Oxycodone) – US: Ranbaxy admits infringement in OxyContin suit – District Court S D New York approves consent judgment between Ranbaxy and Purdue Pharma (Patent Docs) Reyataz (Atazanavir) – US: Complaint filed in Delaware: Infringement of US patent following a Paragraph IV challenge: Bristol-Myers Squibb Co. et al. v. [read post]
3 Mar 2010, 5:05 am
‘The solution lies in resources’ says FDA Commissioner Hamburg (FDA Law Blog) Products Actoplus MET (Pioglitazone) – US: Takeda files patent infringement suit against Aurobindo following Para IV certification as part of ANDA to manufacture generic Actoplus MET (Patent Docs) Advair diskus (Fluticasone, Salmeterol) – US: PTO denies PTE for Advair diskus patent; Office again clarifies that PTEs are not availabile for ‘synergistic combinations’ containing… [read post]
31 Jul 2023, 1:47 pm
” Bristol–Myers Squibb Co. v. [read post]
18 Jan 2009, 4:48 pm
Dasatinib is an anti-cancer drug belonging to the class of tyrosine kinase inhibitors first approved in the United States on June 28, 2006 and marketed by Bristol-Myer Squibb (BMS) under the brand name Sprycel. [read post]
26 Jun 2015, 8:05 am
Bristol-Myers Squibb, CN 91-21770, Tx Dist. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) – US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is the new IFPMA… [read post]
